ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL

被引：1
|
作者：
Brennan, A. [1 ]
Gillett, M. [1 ]
Duenas, A. [1 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66666-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A501 / A501
页数：1
相关论文
共 50 条
  • [31] Pleiotropic effects of add-on therapy with pioglitazone, metformin or the combination of both in patients with type 2 diabetes on stable insulin glargine therapy
    Kleine, I. E.
    Fuchs, W.
    Pfuetzner, A.
    Forst, T.
    Hanefeld, M.
    DIABETOLOGIA, 2011, 54 : S374 - S374
  • [32] DAPAGLIFLOZIN: COST-EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES (T2DM) IN ARGENTINA AND CHILE
    Elgart, J. F.
    Prestes, M.
    Gonzalez, L.
    Asteazaran, S.
    Aiello, E.
    Garrido Lecca, S.
    Alvarez, A.
    Roberts, M.
    Cortes Cuadra, P.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A248 - A248
  • [33] Empaglilozin compared with glimepiride as add-on to metformin for 2 years in patients with type 2 diabetes
    Ridderstrale, M.
    Andersen, K. R.
    Zeller, C.
    Kim, G.
    Woerle, H. J.
    Broedl, U. C.
    DIABETOLOGIA, 2014, 57 : S7 - S8
  • [34] Vildagliptin as add-on therapy to other oral antidiabetics in Japanese patients with type 2 diabetes
    Suzuki, M.
    Hamada, I.
    Odawara, M.
    DIABETOLOGIA, 2012, 55 : S354 - S354
  • [35] Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients
    Cakirca, Mustafa
    Karatoprak, Cumali
    Zorlu, Mehmet
    Kiskac, Muharrem
    Kanat, Mustafa
    Cikrikcioglu, Mehmet Ali
    Soysal, Pinar
    Hursitoglu, Mehmet
    Camli, Ahmet Adil
    Erkoc, Reha
    Abdul-Ghani, Muhammad
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 239 - 243
  • [36] Cost-effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes
    Zupa, Margaret F.
    Codario, Ronald A.
    Smith, Kenneth J.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (15) : 1133 - 1141
  • [37] Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study
    Chen, Yulong
    Li, Quanmin
    Han, Ying
    Ji, Hongmei
    Gu, Mingjun
    Bian, Rongwen
    Ding, Weiguang
    Cheng, Jian
    Mu, Yiming
    DIABETES THERAPY, 2020, 11 (01) : 247 - 257
  • [38] Empagliflozin as add-on to metformin in patients with Type 2 diabetes
    Merker, L.
    Haering, H. U.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 89 - 89
  • [39] Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study
    Yulong Chen
    Quanmin Li
    Ying Han
    Hongmei Ji
    Mingjun Gu
    Rongwen Bian
    Weiguang Ding
    Jian Cheng
    Yiming Mu
    Diabetes Therapy, 2020, 11 : 247 - 257
  • [40] Type 2 diabetes: which drug as add-on to metformin?
    Madsbad, Sten
    LANCET, 2012, 379 (9833): : 2222 - 2223
12345